Naloxone for Opioid-Exposed Newborn Infants | October 2018

Articles

Cochrane Database of Systematic Reviews

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003483.pub3/abstract

Phosphatidylethanol (PEth) in Comparison to Self-Reported Alcohol Consumption among HIV-Infected Women in a Randomized Controlled Trial of Naltrexone for Reducing Hazardous Drinking | December 2017

Articles (Manuscripts-Versions)

PubMed Central>Alcoholism: Clinical and Experimental Research

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750086/

Community Pharmacy-Based Injectable Naltrexone Service Delivery Models and Best Practices | October 2020

Abstracts

Research in Social and Administrative Pharmacy

https://www.sciencedirect.com/science/article/abs/pii/S1551741120311219

The Effects of Extended-Release Injectable Naltrexone and Incentives for Opiate Abstinence in Heroin-Dependent Adults in a Model Therapeutic Workplace: A Randomized Trial | February 2019

Articles (Manuscripts-Versions)

PubMed Central>Drug and Alcohol Dependence

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440824/

Long-Acting Injectable versus Oral Naltrexone Maintenance Therapy with Psychosocial Intervention for Heroin Dependence: A Quasi-Experiment | July 2010

Articles (Manuscripts-Versions)

PubMed Central>Journal of Clinical Psychiatry

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2974056/

Overdose Prevention for Injection Drug Users: Lessons Learned from Naloxone Training and Distribution Programs in New York City | January 2007

Articles

Harm Reduction Journal

http://harmreductionjournal.biomedcentral.com/articles/10.1186/1477-7517-4-3

Impact of Hospital-Administered Extended-Release Naltrexone on Readmission Rates in Patients with Alcohol Use Disorder: A Pilot Study | October 2022

Articles

Primary Care Companion for CNS Disorders

https://doi.org/10.4088/PCC.21m03213

Buprenorphine-Naloxone, Buprenorphine, and Methadone Throughout Pregnancy in Maternal Opioid Use Disorder | December 2022

Articles

Acta Obstetricia et Gynecologica Scandinavica

https://obgyn.onlinelibrary.wiley.com/doi/10.1111/aogs.14497

Buprenorphine+Naloxone plus Naltrexone for the Treatment of Cocaine Dependence: The Cocaine Use Reduction with Buprenorphine (CURB) Study | April 2016

Articles (Manuscripts-Versions)

PubMed Central>Addiction

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940267/

Patients’ Perspectives on Initiating Treatment with Extended-Release Naltrexone (XR-NTX) | October 2020

Abstracts

Journal of Substance Abuse Treatment

https://doi.org/10.1016/j.jsat.2020.108183

Patients’ Beliefs About Medications Are Associated with Stated Preference for Methadone, Buprenorphine, Naltrexone, or No Medication-Assisted Therapy Following Inpatient Opioid Detoxification | March 2016

Articles (Manuscripts-Versions)

PubMed Central>Journal of Substance Abuse Treatment

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892369/

A Randomized Clinical Trial of the Effects of Brief versus Extended Opioid Overdose Education on Naloxone Utilization Outcomes by Individuals with Opioid Use Disorder | May 2022

Articles (Manuscripts-Versions)

PubMed Central>Drug and Alcohol Dependence

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472254/

Pain and Associated Substance Use among Opioid Dependent Individuals Seeking Office-Based Treatment with Buprenorphine-Naloxone: A Needs Assessment Study | April 2013

Articles (Manuscripts-Versions)

PubMed Central>American Journal on Addictions

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641684/

Methadone and Buprenorphine-Naloxone Are Effective in Reducing Illicit Buprenorphine and Other Opioid Use, and Reducing HIV Risk Behavior: Outcomes of a Randomized Trial | July 2013

Articles (Manuscripts-Versions)

PubMed Central>Drug and Alcohol Dependence

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818507/

Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists | September 2016

Articles

Journal of Addiction Medicine

https://journals.lww.com/journaladdictionmedicine/Fulltext/2016/10000/Prescribe_to_Prevent___Overdose_Prevention_and.2.aspx

Extended-Release Naltrexone for Youth with Opioid Use Disorder | April 2021

Abstracts

Journal of Substance Abuse Treatment

https://doi.org/10.1016/j.jsat.2021.108407

Intranasal versus Intravenous Naloxone in Opium Poisoning in Children, a Pilot Study | January 2020

Articles

Journal of Comprehensive Pediatrics

https://dx.doi.org/10.5812/compreped.93342

Barriers to and Recommendations for Take-Home Naloxone Distribution: Perspectives from Opioid Treatment Programs in New Mexico | May 2020

Articles

Harm Reduction Journal

https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-020-00375-2

High Uptake of Naloxone-Based Overdose Prevention Training among Previously Incarcerated Syringe-Exchange Program Participants | June 2015

Articles (Manuscripts-Versions)

PubMed Central>Drug and Alcohol Dependence

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807604/

A Retrospective Study of Hospital Recidivism among Patients with Alcohol Use Disorders Treated with Intramuscular Naltrexone | December 2019

Articles

Cureus

https://doi.org/10.7759/cureus.6287

Acceptability of Prison-Based Take-Home Naloxone Programmes among a Cohort of Incarcerated Men with a History of Regular Injecting Drug Use | September 2018

Articles

Harm Reduction Journal

https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-018-0255-5

Clinical Use of Extended-Release Injectable Naltrexone in the Treatment of Opioid Use Disorder: A Brief Guide | November 2014

Publications (Books-Reports)

Substance Abuse and Mental Health Services Administration

https://store.samhsa.gov/product/Clinical-Use-of-Extended-Release-Injectable-Naltrexone-in-the-Treatment-of-Opioid-Use-Disorder-A-Brief-Guide/SMA14-4892R

Dose-Dependent Reduction of Hazardous Alcohol Use in a Placebo-Controlled Trial of Naltrexone for Smoking Cessation | June 2009

Articles

International Journal of Neuropsychopharmacology

https://doi.org/10.1017/S146114570800936X

Community Distribution of Naloxone: A Systematic Review of Economic Evaluations | November 2021

Articles

PharmacoEconomics – Open

https://link.springer.com/article/10.1007/s41669-021-00309-z

Secondary Analysis of a Randomized Clinical Trial of Naltrexone among Women Living with HIV: Correlations Between Reductions in Self-Reported Alcohol Use and Changes in Phosphatidylethanol | November 2020

Abstracts

Alcoholism: Clinical and Experimental Research

https://doi.org/10.1111/acer.14515

Factors Associated with Willingness to Take Extended Release Naltrexone among Injection Drug Users | May 2015

Articles

Addiction Science and Clinical Practice

https://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0034-5

Exploring the Impact of Gender and Reproductive Status on Outcomes in a Randomized Clinical Trial of Naltrexone Augmentation of Nicotine Patch | June 2010

Articles (Manuscripts-Versions)

PubMed Central>Drug and Alcohol Dependence

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946976/

Efficacy of Long-Acting, Injectable versus Oral Naltrexone for Preventing Admissions for Alcohol Use Disorder | May 2017

Articles

Mental Health Clinician

https://doi.org/10.9740/mhc.2017.05.106

Low-Dose Oral Prolonged-Release Oxycodone/Naloxone for Chronic Pain in Elderly Patients with Cognitive Impairment: An Efficacy-Tolerability Pilot Study | March 2016

Articles

Neuropsychiatric Disease and Treatment

https://doi.org/10.2147/NDT.S98511

Cigarette Smoking Predicts Differential Benefit from Naltrexone for Alcohol Dependence | April 2012

Articles (Manuscripts-Versions)

PubMed Central>Biological Psychiatry

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410039/

Naltrexone-Bupropion (Mysimba) in Management of Obesity: A Systematic Review and Meta-Analysis of Unpublished Clinical Study Reports | February 2020

Articles

NCBI>British Journal of Clinical Pharmacology

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098870/

Implementation of Oral and Extended-Release Naltrexone for the Treatment of Emergency Department Patients with Moderate to Severe Alcohol Use Disorder: Feasibility and Initial Outcomes | August 2021

Abstracts

Annals of Emergency Medicine

https://www.annemergmed.com/article/S0196-0644(21)00398-X/fulltext

Effectiveness and Implementability of State-Level Naloxone Access Policies: Expert Consensus from an Online Modified-Delphi Process | July 2021

Articles (Manuscripts-Versions)

PubMed Central>International Journal of Drug Policy

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671224/

Naloxone Alleviate the Severity of Delirium in Hospitalized Patients with Parkinsonism: Three Case Reports | October 2021

Articles

Frontiers in Psychiatry

https://www.frontiersin.org/articles/10.3389/fpsyt.2021.748958/full

Experiences and Preferences of Opioid-Use-Disorder Patients Who Switched from Brand to Generic Buprenorphine/Naloxone Films: A Case Series | January 2022

Articles

Patient Preference and Adherence

https://doi.org/10.2147/PPA.S336155

Management of Opioid-Dependent Patients: Comparison of the Cost Associated with Use of Buprenorphine/Naloxone or Methadone, and Their Interactions with Concomitant Treatments for Infectious or Psychiatric Comorbidities | September 2015

Articles

Adicciones

https://doi.org/10.20882/adicciones.704

Cost Effectiveness of Injectable Extended Release Naltrexone Compared to Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence | March 2015

Articles (Manuscripts-Versions)

PubMed Central>Substance Abuse

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470733/

Psychological Barriers to Tobacco Cessation in Indian Buprenorphine-Naloxone Maintained Patients: A Pilot Study | August 2015

Articles

Indian Journal of Psychological Medicine

https://journals.sagepub.com/doi/abs/10.4103/0253-7176.162944

Considering the Potential Benefits of Over-the-Counter Naloxone | February 2021

Articles

Integrated Pharmacy Research and Practice

https://doi.org/10.2147/IPRP.S244709

Naltrexone and Combined Behavioral Intervention Effects on Trajectories of Drinking in the COMBINE Study | December 2009

Articles (Manuscripts-Versions)

PubMed Central>Drug and Alcohol Dependence

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821955/

Acute Myocardial Infarction Following Naltrexone Consumption: A Case Report | January 2017

Articles

NCBI>Emergency

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325916/

Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings from Starting Treatment with Agonist Replacement Therapies (START) | July 2013

Articles

NCBI>Journal of Studies on Alcohol and Drugs

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711351/

How Do Naloxone-Based Interventions Work to Reduce Overdose Deaths: A Realist Review | February 2022

Articles

Harm Reduction Journal

https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-022-00599-4

Intravenous Use of Illicit Buprenorphine/Naloxone to Reverse an Acute Heroin Overdose | January 2012

Articles (Manuscripts-Versions)

PubMed Central>Journal of Opioid Management

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343634/

Employment-Based Reinforcement of Adherence to Oral Naltrexone Treatment in Unemployed Injection Drug Users | December 2012

Articles (Manuscripts-Versions)

PubMed Central>Experimental and Clinical Psychopharmacology

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641088/

Treating Opioid Dependence with Injectable Extended-Release Naltrexone (XR-NTX): Who Will Respond? | May 2015

Articles

Journal of Addiction Medicine

http://dx.doi.org/10.1097/ADM.0000000000000125

Knowledge and Possession of Take-Home Naloxone Kits among Street-Involved Youth in a Canadian Setting: A Cohort Study | December 2017

Articles

Harm Reduction Journal

https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-017-0206-6

Evaluation of Naltrexone for Dissociative Symptoms in Borderline Personality Disorder | January 2012

Abstracts

International Clinical Psychopharmacology

https://journals.lww.com/intclinpsychopharm/Abstract/2012/01000/Evaluation_of_naltrexone_for_dissociative_symptoms.7.aspx

Extended-Release Naltrexone Reduces Alcohol Consumption among Released Prisoners with HIV Disease as They Transition to the Community | March 2017

Articles (Manuscripts-Versions)

PubMed Central>Drug and Alcohol Dependence

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407009/

Opioid Overdose Counseling and Prescribing of Naloxone in Rural Community Pharmacies: A Pilot Study | May 2021

Articles

Exploratory Research in Clinical and Social Pharmacy

https://www.sciencedirect.com/science/article/pii/S2667276621000196